Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin α

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2552-2558

  Shen, Jiang Cheng ^a   Unoki, Motoko ^a   Ythier, Damien ^b   Duperray, Alain ^b   Varticovski, Lyuba ^a   Kumamoto, Kensuke ^a   Pedeux, Remy ^b   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; LIPRIN ALPHA1; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN ING4; UNCLASSIFIED DRUG; VINCULIN;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FOCAL ADHESION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; COLONIC NEOPLASMS; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; PROTEIN BINDING; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 34047273596     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3870     Document Type: Article

References (26)

1. He GH, Helbing CC, Wagner MJ, Sensen CW, Riabowol K. Phylogenetic analysis of the ING family of PHD finger proteins. Mol Biol Evol 2005;22:104-16.
2. Russell M, Berardi P, Gong W, Riabowol K. Grow-ING, Age-ING, and Die-ING: ING proteins link cancer, senescence, and apoptosis. Exp Cell Res 2006;312:951-61.
3. Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet 1996;14: 415-20.
4. Nagashima M, Shiseki M, Miura K, et al. DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci U S A 2001;98:9671-6.
5. Nagashima M, Shiseki M, Pedeux R, et al. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene 2003;22:343-50.
6. Shimada Y, Saito A, Suzuki M, Takahashi E, Horie M. Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor. Cytogenet Cell Genet 1998; 83:232-5.
7. Shiseki M, Nagashima M, Pedeux RM, et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 1003;63:2373-8.
8. Gunduz M, Nagatsuka H, Demircan K, et al. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005;356:109-17.
9. Campos EI, Chin MY, Kuo WH, Li, G. Biological functions of the ING family tumor suppressors. Cell Mol Life Sci 2004;61:2597-613.
10. Shi X, Gozani O. The fellowships of the INGs. J Cell Biochem 2005;96:1127-36.
11. Doyon Y, Cayrou C, Ullah M, et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006;21:51-64.
12. Pena PV, Davrazou F, Shi X, et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 2006;442:100-3.
13. Shi X, Hong T, Walter KL, et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006;442:96-9.
14. Ozer A, Wu LC, Bruick RK. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A 2005; 102:7481-6.
15. Garkavtsev I, Kozin SV, Chernova O, et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004;428: 328-32.
16. Kim S, Chin K, Gray JW, Bishop JM. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci U S A 2004;101: 16251-6.
17. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
18. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-9.
19. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998;280:1614-7.
20. Serra-Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A, Streuli M. The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions. EMBO J 1995;14: 2827-38.
21. Miller KE, DeProto J, Kaufmann N, Patel BN, Duckworth A, Van VD. Direct observation demonstrates that Liprin-α is required for trafficking of synaptic vesicles. Curr Biol 2005;15:684-9.
22. Dunah AW, Hueske E, Wyszynski M, et al. LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Nat Neurosci 2005;8:458-67.
23. Pedeux R, Sengupta S, Shen JC, et al. ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol 2005;25:6639-48.
24. Unoki M, Shen JC, Zheng ZM, Harris CC. Novel splice variants of ING4 and their possible roles in regulation of cell growth and motility. J Biol Chem 2006;281:34677-86.
25. Manabe R, Kovalenko M, Webb DJ, Horwitz AR. GIT1 functions in a motile, multi-molecular signaling complex that regulates protrusive activity and cell migration. J Cell Sci 2002;115:1497-510.
26. Schaapveld RQ, Schepens JT, Robinson GW, et al. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev Biol 1997;188:134-46.